Krystal Biotech Inc (KRYS)
163.99
+0.21
(+0.13%)
USD |
NASDAQ |
May 17, 16:00
163.99
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Cash from Operations (Quarterly): 15.89M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.89M |
| December 31, 2023 | -7.232M |
| September 30, 2023 | -21.23M |
| June 30, 2023 | -34.19M |
| March 31, 2023 | -26.16M |
| December 31, 2022 | -22.33M |
| September 30, 2022 | -19.69M |
| June 30, 2022 | -43.06M |
| March 31, 2022 | -15.49M |
| December 31, 2021 | -20.90M |
| September 30, 2021 | -7.255M |
| June 30, 2021 | -10.13M |
| March 31, 2021 | -9.654M |
| December 31, 2020 | -8.024M |
| September 30, 2020 | -6.778M |
| Date | Value |
|---|---|
| June 30, 2020 | -5.054M |
| March 31, 2020 | -6.227M |
| December 31, 2019 | -7.00M |
| September 30, 2019 | -4.266M |
| June 30, 2019 | -4.209M |
| March 31, 2019 | -3.215M |
| December 31, 2018 | -3.518M |
| September 30, 2018 | -1.94M |
| June 30, 2018 | -1.618M |
| March 31, 2018 | -2.369M |
| December 31, 2017 | -2.127M |
| September 30, 2017 | -1.098M |
| June 30, 2017 | -0.408M |
| March 31, 2017 | -0.257M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-43.06M
Minimum
Jun 2022
15.89M
Maximum
Mar 2024
-13.15M
Average
-8.839M
Median
Cash from Operations (Quarterly) Benchmarks
| Axsome Therapeutics Inc | -53.47M |
| Catalyst Pharmaceuticals Inc | 31.92M |
| EyePoint Pharmaceuticals Inc | -31.17M |
| Madrigal Pharmaceuticals Inc | -149.16M |
| Viking Therapeutics Inc | -6.134M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -25.98M |
| Cash from Financing (Quarterly) | 10.58M |
| Free Cash Flow | -54.44M |
| Free Cash Flow Per Share (Quarterly) | 0.4994 |
| Free Cash Flow to Equity (Quarterly) | 14.63M |
| Free Cash Flow Yield | -1.17% |